Together with previous coverage decisions for two GTC hematology profiling tests, the MolDx coverage determination will permit GTC to offer comprehensive genomic profiling for patients with all types of cancer.
Read MoreThe test can determine whether a patient has a number of CGG repeats that is considered either normal, intermediate, premutation, or full mutation.
Read More
The Cobas Zika test detects Zika virus RNA in samples of human plasma and is intended for use in screening blood donations.
Read More
The technology will be based on QuantuMDx’s rapid cell/sample preparation technology, Capture-XT, and Ontera’s nanopore biosensor, currently utilized in its Sam and Duo Nano platforms.
Read More
Sight Diagnostics’ patented Olo analyzer digitizes blood into images to perform the most common blood test in minutes, using just two drops of blood.
Read More